Esperion Therapeutics, Inc. — All Filings
875 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
4
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRSLTR
EFFECT
FWP
NT 10-Q
PRE 14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001959173-25-004621 | Jul 17, 2025 | — |
| 3 | FORM 3 | 0001628280-25-033837 | Jul 2, 2025 | Jul 1, 2025 |
| 4 | FORM 4 | 0001628280-25-033839 | Jul 2, 2025 | Jul 1, 2025 |
| 8-K | 8-K | 0001628280-25-033612 | Jul 1, 2025 | — |
| 4 | FORM 4 | 0001628280-25-032219 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | FORM 4 | 0001628280-25-032217 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | FORM 4 | 0001628280-25-032218 | Jun 18, 2025 | Jun 17, 2025 |
| 144 | — | 0001959173-25-004167 | Jun 17, 2025 | — |
| 144 | — | 0001959173-25-004177 | Jun 17, 2025 | — |
| 144 | — | 0001959173-25-004159 | Jun 17, 2025 | — |
| 4 | FORM 4 | 0001628280-25-028828 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001628280-25-028829 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001628280-25-028824 | Jun 2, 2025 | May 29, 2025 |
| 8-K | 8-K | 0001628280-25-028820 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001628280-25-028826 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001628280-25-028821 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001628280-25-028830 | Jun 2, 2025 | May 29, 2025 |
| 4 | FORM 4 | 0001628280-25-028822 | Jun 2, 2025 | May 29, 2025 |
| 10-Q | 10-Q | 0001628280-25-023498 | May 8, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001628280-25-022397 | May 6, 2025 | — |
| 424B5 | 424B5 | 0001104659-25-042476 | Apr 30, 2025 | — |
| EFFECT | — | 9999999995-25-001285 | Apr 29, 2025 | — |
| CORRESP | — | 0001104659-25-039399 | Apr 25, 2025 | — |
| UPLOAD | — | 0000000000-25-004313 | Apr 23, 2025 | — |
| 4 | FORM 4 | 0001628280-25-018566 | Apr 21, 2025 | Apr 17, 2025 |
| 4 | FORM 4 | 0001628280-25-018567 | Apr 21, 2025 | Apr 17, 2025 |
| S-3 | S-3 | 0001104659-25-036348 | Apr 18, 2025 | — |
| ARS | ARS | 0001628280-25-018232 | Apr 17, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0001628280-25-018229 | Apr 17, 2025 | — |
| DEFA14A | DEFA14A | 0001628280-25-018231 | Apr 17, 2025 | — |
| 144 | — | 0001959173-25-002638 | Apr 17, 2025 | — |
| 144 | — | 0001959173-25-002640 | Apr 17, 2025 | — |
| SCHEDULE 13G/A | — | 0000814133-25-000031 | Apr 7, 2025 | — |
| 8-K | 8-K | 0001628280-25-016794 | Apr 4, 2025 | — |
| 3 | FORM 3 | 0001628280-25-016190 | Apr 2, 2025 | Apr 1, 2025 |
| 4 | FORM 4 | 0001628280-25-016196 | Apr 2, 2025 | Apr 1, 2025 |
| 8-K | 8-K | 0001628280-25-015901 | Apr 1, 2025 | — |
| 4 | FORM 4 | 0001628280-25-013811 | Mar 19, 2025 | Mar 18, 2025 |
| 4 | FORM 4 | 0001628280-25-013812 | Mar 19, 2025 | Mar 18, 2025 |
| 4 | FORM 4 | 0001628280-25-013810 | Mar 19, 2025 | Mar 18, 2025 |
| 144 | — | 0001959173-25-002133 | Mar 18, 2025 | — |
| 144 | — | 0001959173-25-002139 | Mar 18, 2025 | — |
| 144 | — | 0001959173-25-002140 | Mar 18, 2025 | — |
| 4 | FORM 4 | 0001628280-25-013196 | Mar 17, 2025 | Mar 14, 2025 |
| 4 | FORM 4 | 0001628280-25-013195 | Mar 17, 2025 | Mar 14, 2025 |
| 4 | FORM 4 | 0001628280-25-013199 | Mar 17, 2025 | Mar 14, 2025 |
| 4 | FORM 4 | 0001628280-25-013198 | Mar 17, 2025 | Mar 14, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-022052 | Mar 10, 2025 | — |
| 10-K | 10-K | 0001628280-25-011154 | Mar 7, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001628280-25-009619 | Mar 4, 2025 | — |